Clonal evolution in inherited marrow failure syndromes predicts disease progression

2.

Mitchell

E

,

Spencer Chapman

M

,

Williams

N

, et al.

Clonal dynamics of haematopoiesis across the human lifespan

.

Nature

.

2022

;

606

(

7913

):

343

-

350

.

doi:10.1038/s41586-022-04786-y

.

3.

Wlodarski

MW

.

The arrival of personalized genomics in bone marrow failure

.

Haematologica

.

2021

;

106

(

1

):

11

-

13

.

doi:10.3324/haematol.2020.265124

.

4.

Dokal

I

,

Tummala

H

,

Vulliamy

T.

Inherited bone marrow failure in the pediatric patient

.

Blood

.

2022

;

140

(

6

):

556

-

570

.

doi:10.1182/blood.2020006481

.

5.

Tawana

K

,

Brown

AL

,

Churpek

JE

.

Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges

.

Br J Haematol

.

2022

;

196

(

6

):

1293

-

1310

.

doi:10.1111/bjh.17855

.

6.

Polprasert

C

,

Schulze

I

,

Sekeres

MA

, et al.

Inherited and somatic defects in DDX41 in myeloid neoplasms

.

Cancer Cell

.

2015

;

27

(

5

):

658

-

670

.

doi:10.1016/j.ccell.2015.03.017

.

7.

Chen

D-H

,

Below

J-E

,

Shimamura

A

, et al.

Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L

.

Am J Hum Genet

.

2016

;

98

(

6

):

1146

-

1158

.

doi:10.1016/j.ajhg.2016.04.009

.

8.

Narumi

S

,

Amano

N

,

Ishii

T

, et al.

SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7

.

Nat Genet

.

2016

;

48

(

7

):

792

-

797

.

doi:10.1038/ng.3569

.

9.

Armanios

M.

The role of telomeres in human disease

.

Annu Rev Genom Hum Genet

.

2022

;

23

(

1

):

363

-

381

.

doi:10.1146/annurev-genom-010422-091101

.

10.

Churpek

JE

,

Lorenz

R

,

Nedumgottil

S

, et al.

Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes

.

Leuk Lymphoma

.

2013

;

54

(

1

):

28

-

35

.

doi:10.3109/10428194.2012.701738

.

11.

DiNardo

CD

,

Bannon

SA

,

Routbort

M

, et al.

Evaluation of patients and families with concern for predispositions to hematologic malignancies within the hereditary hematologic malignancy clinic (HHMC)

.

Clin Lymphoma Myeloma Leuk

.

2016

;

16

(

7

):

417

-

428.e2428e2

.

doi:10.1016/j.clml.2016.04.001

.

12.

Drazer

MW

,

Kadri

S

,

Sukhanova

M

, et al.

Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies

.

Blood Adv

.

2018

;

2

(

2

):

146

-

150

.

doi:10.1182/bloodadvances.2017013037

.

13.

Schratz

KE

,

DeZern

AE

.

Genetic predisposition to myelodysplastic syndrome in clinical practice

.

Hematol/Oncol Clin N Am

.

2020

;

34

(

2

):

333

-

356

.

doi:10.1016/j.hoc.2019.10.002

.

14.

Churpek

JE

,

Artz

A

,

Bishop

M

,

Liu

H

,

Godley

LA

.

Correspondence regarding the consensus statement from the worldwide network for blood and marrow transplantation standing committee on donor issues

.

Biol Blood Marrow Transplant

.

2016

;

22

(

1

):

183

-

184

.

doi:10.1016/j.bbmt.2015.10.008

.

15.

Wlodarski

MW

,

Hirabayashi

S

,

Pastor

V

, et al;

EWOG-MDS

.

Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

.

Blood

.

2016

;

127

(

11

):

1387

-

1397

; quiz 1518.

doi:10.1182/blood-2015-09-669937

.

16.

Schwartz

JR

,

Ma

J

,

Lamprecht

T

, et al.

The genomic landscape of pediatric myelodysplastic syndromes

.

Nat Commun

.

2017

;

8

(

1

):

1557

.

doi:10.1038/s41467-017-01590-5

.

17.

Schratz

KE

.

Extrahematopoietic manifestations of the short telomere syndromes

.

Hematology. Am Soc Hematol Educ Program

.

2020

;

2020

(

1

):

115

-

122

.

doi:10.1182/hematology.2020000170

.

18.

Schratz

KE

,

Haley

L

,

Danoff

SK

, et al.

Cancer spectrum and outcomes in the Mendelian short telomere syndromes

.

Blood

.

2020

;

135

(

22

):

1946

-

1956

.

doi:10.1182/blood.2019003264

.

19.

Brown

AL

,

Arts

P

,

Carmichael

CL

, et al.

RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML

.

Blood Adv

.

2020

;

4

(

6

):

1131

-

1144

.

doi:10.1182/bloodadvances.2019000901

.

20.

Antony-Debré

I

,

Duployez

N

,

Bucci

M

, et al.

Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia

.

Leukemia

.

2016

;

30

(

4

):

999

-

1002

.

doi:10.1038/leu.2015.236

.

21.

Cioc

AM

,

Wagner

JE

,

MacMillan

ML

,

DeFor

T

,

Hirsch

B.

Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with Fanconi anemia: morphologic and cytogenetic characteristics

.

Am J Clin Pathol

.

2010

;

133

(

1

):

92

-

100

.

doi:10.1309/ajcp7w9vmjenzovg

.

22.

Myers

KC

,

Furutani

E

,

Weller

E

, et al.

Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study

.

Lancet Haematol

.

2020

;

7

(

3

):

e238

-

e246

.

doi:10.1016/S2352-3026(19)30206-6

.

23.

Sahoo

SS

,

Pastor

VB

,

Goodings

C

, et al;

European Working Group of MDS in Children (EWOG-MDS)

.

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

.

Nat Med

.

2021

;

27

(

10

):

1806

-

1817

.

doi:10.1038/s41591-021-01511-6

.

24.

Buonocore

F

,

Kühnen

P

,

Suntharalingham

JP

, et al.

Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans

.

J Clin Invest

.

2017

;

127

(

5

):

1700

-

1713

.

doi:10.1172/JCI91913

.

25.

Tesi

B

,

Davidsson

J

,

Voss

M

, et al.

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms

.

Blood

.

2017

;

129

(

16

):

2266

-

2279

.

doi:10.1182/blood-2016-10-743302

.

26.

Kozyra

EJ

,

Göhring

G

,

Hickstein

DD

, et al.

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

.

Blood

.

2021

;

138

(

23

):

2441

-

2445

.

doi:10.1182/blood.2021012781

.

27.

Hahn

CN

,

Chong

C-E

,

Carmichael

C-L

, et al.

Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia

.

Nat Genet

.

2011

;

43

(

10

):

1012

-

1017

.

doi:10.1038/ng.913

.

28.

Hsu

AP

,

Sampaio

EP

,

Khan

J

, et al.

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome

.

Blood

.

2011

;

118

(

10

):

2653

-

2655

.

doi:10.1182/blood-2011-05-356352

.

29.

Spinner

MA

,

Sanchez

LA

,

Hsu

AP

, et al.

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity

.

Blood

.

2014

;

123

(

6

):

809

-

821

.

doi:10.1182/blood-2013-07-515528

.

30.

Schratz

KE

,

Flasch

DA

,

Atik

CC

, et al.

T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers

.

Cancer Cell

.

2023

;

41

(

4

):

807

-

817.e6817e6

.

doi:10.1016/j.ccell.2023.03.005

.

31.

Holme

H

,

Hossain

U

,

Kirwan

M

,

Walne

A

,

Vulliamy

T

,

Dokal

I.

Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia

.

Br J Haematol

.

2012

;

158

(

2

):

242

-

248

.

doi:10.1111/j.1365-2141.2012.09136.x

.

32.

Reilly

CR

,

Myllymäki

M

,

Redd

R

, et al.

The clinical and functional effects of TERT variants in myelodysplastic syndrome

.

Blood

.

2021

;

138

(

10

):

898

-

911

.

doi:10.1182/blood.2021011075

.

33.

Bluteau

O

,

Sebert

M

,

Leblanc

T

, et al.

A landscape of germ line mutations in a cohort of inherited bone marrow failure patients

.

Blood

.

2018

;

131

(

7

):

717

-

732

.

doi:10.1182/blood-2017-09-806489

.

34.

Keel

SB

,

Scott

A

,

Sanchez-Bonilla

M

, et al.

Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients

.

Haematologica

.

2016

;

101

(

11

):

1343

-

1350

.

doi:10.3324/haematol.2016.149476

.

35.

Armanios

M

,

Alder

JK

,

Parry

EM

,

Karim

B

,

Strong

MA

,

Greider

CW

.

Short telomeres are sufficient to cause the degenerative defects associated with aging

.

Am J Hum Genet

.

2009

;

85

(

6

):

823

-

832

.

doi:10.1016/j.ajhg.2009.10.028

.

36.

Wagner

CL

,

Hanumanthu

VS

,

Talbot

CC

Jr, et al.

Short telomere syndromes cause a primary T cell immunodeficiency

.

J Clin Invest

.

2018

;

128

(

12

):

5222

-

5234

.

doi:10.1172/JCI120216

.

37.

Schratz

KE

,

Armanios

M.

Cancer and myeloid clonal evolution in the short telomere syndromes

.

Curr Opin Genet Dev

.

2020

;

60

:

112

-

118

.

doi:10.1016/j.gde.2020.02.019

.

38.

Alder

JK

,

Armanios

M.

Telomere-mediated lung disease

.

Physiol Rev

.

2022

;

102

(

4

):

1703

-

1720

.

doi:10.1152/physrev.00046.2021

.

39.

DeBoy

EA

,

Tassia

MG

,

Schratz

KE

, et al.

Familial clonal hematopoiesis in a long telomere syndrome

.

N Engl J Med

.

2023

;

388

(

26

):

2422

-

2433

.

doi:10.1056/NEJMoa2300503

.

40.

Duployez

N

,

Largeaud

L

,

Duchmann

M

, et al.

Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

.

Blood

.

2022

;

140

(

7

):

756

-

768

.

doi:10.1182/blood.2021015328

.

41.

Sébert

M

,

Passet

M

,

Raimbault

A

, et al.

Germline DDX41 mutations define a significant entity within adult MDS/AML patients

.

Blood

.

2019

;

134

(

17

):

1441

-

1444

.

doi:10.1182/blood.2019000909

.

42.

Lewinsohn

M

,

Brown

AL

,

Weinel

LM

, et al.

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies

.

Blood

.

2016

;

127

(

8

):

1017

-

1023

.

doi:10.1182/blood-2015-10-676098

.

43.

Steensma

DP

,

Bejar

R

,

Jaiswal

S

, et al.

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

.

Blood

.

2015

;

126

(

1

):

9

-

16

.

doi:10.1182/blood-2015-03-631747

.

44.

Genovese

G

,

Kähler

AK

,

Handsaker

RE

, et al.

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

.

N Engl J Med

.

2014

;

371

(

26

):

2477

-

2487

.

doi:10.1056/NEJMoa1409405

.

45.

Jaiswal

S

,

Fontanillas

P

,

Flannick

J

, et al.

Age-related clonal hematopoiesis associated with adverse outcomes

.

N Engl J Med

.

2014

;

371

(

26

):

2488

-

2498

.

doi:10.1056/nejmoa1408617

.

46.

Weeks

LD

,

Niroula

A

,

Neuberg

D

, et al.

Prediction of risk for myeloid malignancy in clonal hematopoiesis

.

NEJM Evid

.

2023

;

2

(

5

).

doi:10.1056/evidoa2200310

.

47.

Kennedy

AL

,

Myers

KC

,

Bowman

J

, et al.

Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

.

Nat Commun

.

2021

;

12

(

1

):

1334

.

doi:10.1038/s41467-021-21588-4

.

48.

Heidemann

S

,

Bursic

B

,

Zandi

S

, et al.

Cellular and molecular architecture of hematopoietic stem cells and progenitors in genetic models of bone marrow failure

.

JCI Insight

.

2020

;

5

(

4

).

doi:10.1172/jci.insight.131018

.

49.

Schratz

KE

,

Gaysinskaya

V

,

Cosner

ZL

, et al.

Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders

.

J Clin Invest

.

2021

;

131

(

18

).

doi:10.1172/JCI147598

.

50.

Xia

J

,

Miller

CA

,

Baty

J

, et al.

Somatic mutations and clonal hematopoiesis in congenital neutropenia

.

Blood

.

2018

;

131

(

4

):

408

-

416

.

doi:10.1182/blood-2017-08-801985

.

51.

Homan

CC

,

Drazer

MW

,

Yu

K

, et al.

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variants

.

Blood Adv

.

2023

.

doi:10.1182/bloodadvances.2023010045

.

52.

Sahoo

SS

,

Kozyra

EJ

,

Wlodarski

MW

.

Germline predisposition in myeloid neoplasms: unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes

.

Best Pract Res Clin Haematol

.

2020

;

33

(

3

):

101197

.

doi:10.1016/j.beha.2020.101197

.

53.

Revy

P

,

Kannengiesser

C

,

Fischer

A.

Somatic genetic rescue in Mendelian haematopoietic diseases

.

Nat Rev Genet

.

2019

;

20

(

10

):

582

-

598

.

doi:10.1038/s41576-019-0139-x

.

54.

Catto

LFB

,

Borges

G

,

Pinto

AL

, et al.

Somatic genetic rescue in hematopoietic cells in GATA2 deficiency

.

Blood

.

2020

;

136

(

8

):

1002

-

1005

.

doi:10.1182/blood.2020005538

.

55.

Wong

JC

,

Bryant

V

,

Lamprecht

T

, et al.

Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes

.

JCI Insight

.

2018

;

3

(

14

):

e121086

.

doi:10.1172/jci.insight.121086

.

56.

Inaba

T

,

Honda

H

,

Matsui

H.

The enigma of monosomy 7

.

Blood

.

2018

;

131

(

26

):

2891

-

2898

.

doi:10.1182/blood-2017-12-822262

.

57.

Alder

JK

,

Stanley

SE

,

Wagner

CL

,

Hamilton

M

,

Hanumanthu

VS

,

Armanios

M.

Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis

.

Chest

.

2015

;

147

(

5

):

1361

-

1368

.

doi:10.1378/chest.14-1947

.

58.

Jongmans

MCJ

,

Verwiel

ETP

,

Heijdra

Y

, et al.

Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita

.

Am J Hum Genet

.

2012

;

90

(

3

):

426

-

433

.

doi:10.1016/j.ajhg.2012.01.004

.

59.

Perdigones

N

,

Perin

JC

,

Schiano

I

, et al.

Clonal hematopoiesis in patients with dyskeratosis congenita

.

Am J Hematol

.

2016

;

91

(

12

):

1227

-

1233

.

doi:10.1002/ajh.24552

.

60.

Gutierrez-Rodrigues

F

,

Donaires

FS

,

Pinto

A

, et al.

Pathogenic TERT promoter variants in telomere diseases

.

Genet Med

.

2019

;

21

(

7

):

1594

-

1602

.

doi:10.1038/s41436-018-0385-x

.

61.

Maryoung

L

,

Yue

Y

,

Young

A

, et al.

Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations

.

J Clin Invest

.

2017

;

127

(

3

):

982

-

986

.

doi:10.1172/JCI91161

.

62.

Lorbeer

FK

,

Hockemeyer

D.

TERT promoter mutations and telomeres during tumorigenesis

.

Curr Opin Genet Dev

.

2020

;

60

:

56

-

62

.

doi:10.1016/j.gde.2020.02.001

.

63.

Boocock

GRB

,

Morrison

JA

,

Popovic

M

, et al.

Mutations in SBDS are associated with Shwachman–Diamond syndrome

.

Nat Genet

.

2003

;

33

(

1

):

97

-

101

.

doi:10.1038/ng1062

.

64.

Finch

AJ

,

Hilcenko

C

,

Basse

N

, et al.

Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome

.

Genes Dev

.

2011

;

25

(

9

):

917

-

929

.

doi:10.1101/gad.623011

.

65.

Wong

CC

,

Traynor

D

,

Basse

N

,

Kay

RR

,

Warren

AJ

.

Defective ribosome assembly in Shwachman-Diamond syndrome

.

Blood

.

2011

;

118

(

16

):

4305

-

4312

.

doi:10.1182/blood-2011-06-353938

.

66.

Pressato

B

,

Valli

R

,

Marletta

C

, et al.

Deletion of chromosome 20 in bone marrow of patients with Shwachman-Diamond syndrome, loss of the EIF6 gene and benign prognosis

.

Br J Haematol

.

2012

;

157

(

4

):

503

-

505

.

doi:10.1111/j.1365-2141.2012.09033.x

.

67.

Valli

R

,

Pressato

B

,

Marletta

C

, et al.

Different loss of material in recurrent chromosome 20 interstitial deletions in Shwachman-Diamond syndrome and in myeloid neoplasms

.

Mol Cytogenet

.

2013

;

6

(

1

):

56

.

doi:10.1186/1755-8166-6-56

.

68.

Minelli

A

,

Maserati

E

,

Nicolis

E

, et al.

The isochromosome i(7)(q10) carrying c.258 + 2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome

.

Leukemia

.

2009

;

23

(

4

):

708

-

711

.

doi:10.1038/leu.2008.369

.

69.

Austin

KM

,

Leary

RJ

,

Shimamura

A.

The Shwachman-Diamond SBDS protein localizes to the nucleolus

.

Blood

.

2005

;

106

(

4

):

1253

-

1258

.

doi:10.1182/blood-2005-02-0807

.

70.

Khan

AW

,

Kennedy

A

,

Furutani

E

, et al.

The frequent and clinically benign anomalies of chromosomes 7 and 20 in Shwachman-diamond syndrome may be subject to further clonal variations

.

Mol Cytogenet

.

2021

;

14

(

1

):

54

.

doi:10.1186/s13039-021-00575-w

.

71.

Valli

R

,

Minelli

A

,

Galbiati

M

, et al.

Shwachman-Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic instability

.

Br J Haematol

.

2019

;

184

(

6

):

974

-

981

.

doi:10.1111/bjh.15729

.

72.

Furutani

E

,

Liu

S

,

Galvin

A

, et al.

Hematologic complications with age in Shwachman-Diamond syndrome

.

Blood Adv

.

2022

;

6

(

1

):

297

-

306

.

doi:10.1182/bloodadvances.2021005539

.

73.

Tan

S

,

Kermasson

L

,

Hilcenko

C

, et al.

Somatic genetic rescue of a germline ribosome assembly defect

.

Nat Commun

.

2021

;

12

(

1

):

5044

.

doi:10.1038/s41467-021-24999-5

.

74.

Lucas

F

,

Michaels

PD

,

Wang

D

,

Kim

AS

.

Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing

.

Blood Adv

.

2020

;

4

(

18

):

4362

-

4365

.

doi:10.1182/bloodadvances.2020002306

.

75.

Glembotsky

AC

,

Marin Oyarzún

CP

,

De Luca

G

, et al.

First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: correlation with the clinical phenotype

.

Haematologica

.

2020

;

105

(

10

):

e535

.

doi:10.1182/bloodadvances.2020002306

.